Elis: raises FY growth guidance
(CercleFinance.com) - Elis has published H1 sales of E2,246m, up 6.
9% (of which +5.5% organic).
While the adjusted EBITDA margin improved by 120 bp to 34.5% of sales, net income contracted by 14.1% to E119.1m, in line with the expected half-year sequence.
Recurring net income was up +0.9% to E208.7m, with recurring EPS up +1.6% to E0.83 (number of shares on a diluted basis).
Elis updates its outlook and targets 2024 organic sales growth of +5.2% and +5.5% (previously expected at around +5%). Its adjusted EBITDA margin is now expected between 35.2% and 35.5% (previously expected to be close to 35%).
Lastly, EPS before non-recurring items is still expected to exceed E1.75 on a diluted basis.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
9% (of which +5.5% organic).
While the adjusted EBITDA margin improved by 120 bp to 34.5% of sales, net income contracted by 14.1% to E119.1m, in line with the expected half-year sequence.
Recurring net income was up +0.9% to E208.7m, with recurring EPS up +1.6% to E0.83 (number of shares on a diluted basis).
Elis updates its outlook and targets 2024 organic sales growth of +5.2% and +5.5% (previously expected at around +5%). Its adjusted EBITDA margin is now expected between 35.2% and 35.5% (previously expected to be close to 35%).
Lastly, EPS before non-recurring items is still expected to exceed E1.75 on a diluted basis.
Copyright (c) 2024 CercleFinance.com. All rights reserved.